← Back
Data updated: Mar 29, 2026
TREVENA
Neurology
Pharma
TREVENA is a pharmaceutical company focused on Neurology. Key products include OLINVYK.
2020
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2020-08-07
- Latest
- 2025-12-22
- Applications
- 1